Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection.
Kevin ZhangPatricia BeckettSalaheddin AbouanaserMarek SmiejaPublished in: Antimicrobial stewardship & healthcare epidemiology : ASHE (2021)
Initial vancomycin was associated with a reduced rate of new incident infection in the treatment of adult inpatients with first-episode non-severe CDI. These findings support the use of initial vancomycin for all inpatients with CDI, when fidaxomicin is unavailable.